News

Midlife PSA measure predicted lethal prostate cancer

Publish date: May 20, 2014

 

AT THE AUA ANNUAL MEETING

Dr. Preston reported having no disclosures. Dr. Eggener has been a consultant, adviser, lecturer, investigator, and/or proctor for Genomic Health, Intuitive Surgical Janssen Pharmaceuticals, and Myriad Genetics.

Pages

Recommended Reading

VIDEO: HPV testing predicted to displace most Pap smears
MDedge Internal Medicine
Vitamin D deficiency predicts aggressive prostate cancer
MDedge Internal Medicine
Panel recommends against low-dose CT for lung cancer in Medicare patients
MDedge Internal Medicine
CDC: Policy changes could prevent 100,000 deaths a year
MDedge Internal Medicine
Expanded cytoreduction criteria improved survival of carcinoid liver metastases
MDedge Internal Medicine
Topical tazarotene did not improve response to imiquimod 5% in lentigo maligna
MDedge Internal Medicine
EndoRings-assisted colonoscopy hikes polyp, adenoma detection
MDedge Internal Medicine
Polyp, adenoma detection rises with Endocuff device
MDedge Internal Medicine
Delaying ADT for PSA-only prostate cancer relapse appears safe
MDedge Internal Medicine
Low-dose CT could up early lung cancer detection - at a price
MDedge Internal Medicine